FDA Panel Urges Sterner Warnings for Bone-Building Drugs

Try Our New Player
NewsyVideos
1.1K
13 views
  • About
  • Export
  • Add to
An FDA panel has recommended stronger caution for bone-building drug labels in light of concerns over long-term use.

0 comments